Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Substance-Related Disorders | 32 | 2024 | 4257 | 4.520 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 19 | 2024 | 3658 | 2.240 |
Why?
|
Conduct Disorder | 6 | 2023 | 241 | 1.410 |
Why?
|
Opioid-Related Disorders | 6 | 2023 | 2064 | 1.190 |
Why?
|
Central Nervous System Stimulants | 10 | 2023 | 1148 | 1.120 |
Why?
|
Parents | 5 | 2021 | 3405 | 0.690 |
Why?
|
Comorbidity | 10 | 2023 | 10388 | 0.680 |
Why?
|
Psychoses, Substance-Induced | 1 | 2019 | 96 | 0.670 |
Why?
|
Physician Impairment | 1 | 2019 | 73 | 0.640 |
Why?
|
Behavior, Addictive | 1 | 2023 | 462 | 0.600 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2021 | 941 | 0.590 |
Why?
|
Mental Disorders | 4 | 2021 | 6600 | 0.560 |
Why?
|
Schools | 2 | 2017 | 1433 | 0.560 |
Why?
|
Adolescent | 34 | 2024 | 85784 | 0.520 |
Why?
|
Outpatients | 1 | 2023 | 1487 | 0.510 |
Why?
|
Autistic Disorder | 2 | 2021 | 1185 | 0.510 |
Why?
|
Physicians, Women | 1 | 2021 | 486 | 0.500 |
Why?
|
Siblings | 2 | 2016 | 854 | 0.500 |
Why?
|
Psychometrics | 2 | 2021 | 3002 | 0.490 |
Why?
|
Methylphenidate | 4 | 2019 | 473 | 0.490 |
Why?
|
Child of Impaired Parents | 1 | 2018 | 455 | 0.480 |
Why?
|
Checklist | 1 | 2020 | 833 | 0.450 |
Why?
|
Physicians | 2 | 2023 | 4567 | 0.430 |
Why?
|
Young Adult | 25 | 2024 | 56434 | 0.420 |
Why?
|
Substance Abuse, Intravenous | 3 | 2022 | 525 | 0.390 |
Why?
|
Social Support | 1 | 2021 | 2118 | 0.390 |
Why?
|
Students | 4 | 2020 | 1651 | 0.380 |
Why?
|
Alcoholism | 2 | 2019 | 1906 | 0.380 |
Why?
|
Psychiatry | 1 | 2022 | 1695 | 0.360 |
Why?
|
Family | 2 | 2019 | 3147 | 0.350 |
Why?
|
Communication | 2 | 2023 | 3750 | 0.350 |
Why?
|
Psychopathology | 2 | 2024 | 409 | 0.350 |
Why?
|
Attitude of Health Personnel | 1 | 2023 | 3842 | 0.330 |
Why?
|
Delivery of Health Care | 2 | 2024 | 5321 | 0.320 |
Why?
|
Euphoria | 2 | 2018 | 67 | 0.310 |
Why?
|
Bipolar Disorder | 6 | 2023 | 5027 | 0.310 |
Why?
|
Child | 17 | 2023 | 77708 | 0.290 |
Why?
|
Harm Reduction | 3 | 2022 | 129 | 0.290 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8642 | 0.280 |
Why?
|
Depressive Disorder, Major | 2 | 2022 | 4644 | 0.270 |
Why?
|
Humans | 53 | 2024 | 744376 | 0.270 |
Why?
|
Naltrexone | 2 | 2018 | 307 | 0.260 |
Why?
|
Analgesics, Opioid | 2 | 2023 | 3677 | 0.260 |
Why?
|
Patient Acceptance of Health Care | 2 | 2021 | 3020 | 0.260 |
Why?
|
Adult | 21 | 2024 | 214056 | 0.230 |
Why?
|
Longitudinal Studies | 6 | 2022 | 13988 | 0.230 |
Why?
|
Telemedicine | 1 | 2020 | 2872 | 0.220 |
Why?
|
Residential Treatment | 1 | 2024 | 111 | 0.220 |
Why?
|
Interview, Psychological | 2 | 2016 | 812 | 0.200 |
Why?
|
Antisocial Personality Disorder | 2 | 2023 | 228 | 0.200 |
Why?
|
Depression | 1 | 2021 | 7766 | 0.190 |
Why?
|
Pandemics | 1 | 2021 | 8386 | 0.190 |
Why?
|
Nursing Staff, Hospital | 1 | 2024 | 346 | 0.190 |
Why?
|
Massachusetts | 6 | 2024 | 8662 | 0.190 |
Why?
|
Child Care | 1 | 2021 | 119 | 0.180 |
Why?
|
Focus Groups | 1 | 2024 | 1321 | 0.170 |
Why?
|
Female | 26 | 2024 | 380200 | 0.170 |
Why?
|
Tetrahydrofolates | 1 | 2019 | 61 | 0.160 |
Why?
|
Case-Control Studies | 7 | 2020 | 21747 | 0.160 |
Why?
|
Marijuana Abuse | 1 | 2022 | 403 | 0.160 |
Why?
|
Efficiency | 1 | 2021 | 462 | 0.150 |
Why?
|
Behavior Therapy | 1 | 2022 | 865 | 0.140 |
Why?
|
Resilience, Psychological | 1 | 2024 | 676 | 0.140 |
Why?
|
Mass Screening | 3 | 2021 | 5255 | 0.140 |
Why?
|
Risk Factors | 8 | 2022 | 72295 | 0.140 |
Why?
|
Narcotic Antagonists | 2 | 2018 | 562 | 0.140 |
Why?
|
Male | 21 | 2024 | 350118 | 0.140 |
Why?
|
Consensus Development Conferences as Topic | 3 | 2021 | 170 | 0.140 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 25041 | 0.130 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 501 | 0.130 |
Why?
|
Cannabis | 1 | 2022 | 440 | 0.130 |
Why?
|
Qualitative Research | 1 | 2024 | 2682 | 0.130 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2017 | 1344 | 0.130 |
Why?
|
Social Environment | 1 | 2020 | 1023 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17445 | 0.130 |
Why?
|
Child Psychiatry | 1 | 2017 | 220 | 0.120 |
Why?
|
Prescriptions | 1 | 2017 | 387 | 0.120 |
Why?
|
United States | 5 | 2023 | 69869 | 0.120 |
Why?
|
Postpartum Period | 1 | 2019 | 1086 | 0.110 |
Why?
|
ROC Curve | 1 | 2020 | 3527 | 0.110 |
Why?
|
Psychotherapy | 1 | 2022 | 1643 | 0.110 |
Why?
|
Mood Disorders | 1 | 2019 | 1106 | 0.110 |
Why?
|
Program Evaluation | 1 | 2021 | 2488 | 0.100 |
Why?
|
Evidence-Based Medicine | 2 | 2021 | 3610 | 0.100 |
Why?
|
Epidemics | 1 | 2017 | 523 | 0.100 |
Why?
|
Consensus | 1 | 2020 | 2960 | 0.100 |
Why?
|
Suicide, Attempted | 1 | 2019 | 1218 | 0.100 |
Why?
|
Delayed-Action Preparations | 3 | 2019 | 968 | 0.100 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39052 | 0.090 |
Why?
|
Retrospective Studies | 5 | 2023 | 77459 | 0.090 |
Why?
|
Anxiety Disorders | 1 | 2021 | 2690 | 0.090 |
Why?
|
Patient Care Team | 1 | 2021 | 2531 | 0.090 |
Why?
|
Mothers | 1 | 2020 | 2165 | 0.090 |
Why?
|
Substance Abuse Detection | 1 | 2012 | 283 | 0.080 |
Why?
|
Mental Health | 1 | 2023 | 3014 | 0.080 |
Why?
|
Prevalence | 4 | 2019 | 15221 | 0.080 |
Why?
|
Family Health | 1 | 2014 | 1281 | 0.080 |
Why?
|
Antipsychotic Agents | 1 | 2022 | 3057 | 0.080 |
Why?
|
Dietary Supplements | 2 | 2019 | 3296 | 0.080 |
Why?
|
Health Services Accessibility | 2 | 2021 | 5135 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4296 | 0.070 |
Why?
|
Sex Factors | 2 | 2016 | 10400 | 0.070 |
Why?
|
Pediatrics | 1 | 2020 | 3475 | 0.070 |
Why?
|
Adolescent Behavior | 1 | 2014 | 1151 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15078 | 0.060 |
Why?
|
Double-Blind Method | 4 | 2019 | 12025 | 0.060 |
Why?
|
Universities | 2 | 2020 | 956 | 0.060 |
Why?
|
Menopause | 1 | 2011 | 1626 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7785 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19905 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12356 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13409 | 0.050 |
Why?
|
United States Substance Abuse and Mental Health Services Administration | 1 | 2021 | 20 | 0.050 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2023 | 304 | 0.050 |
Why?
|
Institutionalization | 1 | 2021 | 104 | 0.050 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2021 | 295 | 0.050 |
Why?
|
Episode of Care | 1 | 2021 | 126 | 0.050 |
Why?
|
Self Report | 2 | 2022 | 3557 | 0.050 |
Why?
|
Anger | 1 | 2022 | 402 | 0.040 |
Why?
|
Risperidone | 1 | 2022 | 383 | 0.040 |
Why?
|
Cognition | 1 | 2017 | 6770 | 0.040 |
Why?
|
Smoking | 1 | 2016 | 8987 | 0.040 |
Why?
|
Empathy | 1 | 2024 | 474 | 0.040 |
Why?
|
Folate Receptor 1 | 1 | 2019 | 36 | 0.040 |
Why?
|
GTP Cyclohydrolase | 1 | 2019 | 46 | 0.040 |
Why?
|
Antimanic Agents | 1 | 2022 | 522 | 0.040 |
Why?
|
Neonatal Abstinence Syndrome | 1 | 2019 | 109 | 0.040 |
Why?
|
Aggression | 1 | 2023 | 753 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6489 | 0.040 |
Why?
|
Diet Therapy | 1 | 2019 | 154 | 0.040 |
Why?
|
Delphi Technique | 1 | 2020 | 779 | 0.040 |
Why?
|
Treatment Outcome | 6 | 2020 | 63115 | 0.040 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2019 | 312 | 0.040 |
Why?
|
Standard of Care | 1 | 2021 | 564 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10943 | 0.040 |
Why?
|
Prospective Studies | 4 | 2022 | 53291 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2022 | 1101 | 0.030 |
Why?
|
Housing | 1 | 2021 | 664 | 0.030 |
Why?
|
Live Birth | 1 | 2019 | 512 | 0.030 |
Why?
|
Opiate Substitution Treatment | 1 | 2019 | 404 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 23336 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2019 | 6994 | 0.030 |
Why?
|
Pilot Projects | 2 | 2019 | 8319 | 0.030 |
Why?
|
Thiazoles | 1 | 2022 | 1483 | 0.030 |
Why?
|
Needs Assessment | 1 | 2021 | 1146 | 0.030 |
Why?
|
Child, Preschool | 1 | 2017 | 41005 | 0.030 |
Why?
|
Health Resources | 1 | 2021 | 911 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2019 | 824 | 0.030 |
Why?
|
Parenting | 1 | 2019 | 679 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2021 | 1049 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2021 | 1425 | 0.030 |
Why?
|
Peer Group | 1 | 2017 | 635 | 0.030 |
Why?
|
Piperazines | 1 | 2022 | 2488 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2021 | 2418 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 3914 | 0.020 |
Why?
|
Middle Aged | 2 | 2023 | 213388 | 0.020 |
Why?
|
Autoantibodies | 1 | 2019 | 2036 | 0.020 |
Why?
|
Executive Function | 1 | 2019 | 1364 | 0.020 |
Why?
|
Motivation | 1 | 2019 | 1971 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4933 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2373 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2602 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 4982 | 0.020 |
Why?
|
Boston | 1 | 2022 | 9312 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8340 | 0.020 |
Why?
|
Hot Flashes | 1 | 2011 | 316 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 29144 | 0.020 |
Why?
|
Infant | 2 | 2020 | 35134 | 0.020 |
Why?
|
Placebos | 1 | 2011 | 1676 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7914 | 0.020 |
Why?
|
Quality Improvement | 1 | 2021 | 3749 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2021 | 4369 | 0.020 |
Why?
|
Docosahexaenoic Acids | 1 | 2011 | 875 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9688 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 12803 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18373 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2011 | 6038 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 25628 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 40558 | 0.010 |
Why?
|
Concepts
(179)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(36)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_